Sfoglia per AUTORE
BRUNELLI M
Collezione AOU San Luigi di Orbassano

  

Items : 7

Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study. in European urology / Eur Urol. 2024 Nov;86(5):411-419. doi: 10.1016/j.eururo.2024.02.014. Epub 2024 Mar 22.
2024
AOU San Luigi di Orbassano

Iacovelli R; Ciccarese C; Buti S; Zucali PA; Fantinel E; Bimbatti D; Verzoni E; Accettura C; Bonomi L; Buttigliero C; Fornarini G; Pipitone S; Atzori F; Masini C; Massari F; Primi F; Strusi A; Giudice GC; Perrino M; Maruzzo M; Milella M; Giannarelli D; Brunelli M; Procopio G; Tortora G;

STING is a prognostic factor related to tumor necrosis, sarcomatoid dedifferentiation, and distant metastasis in clear cell renal cell carcinoma. in Virchows Archiv : an international journal of pathology / Virchows Arch. 2023 Jul;483(1):87-96. doi: 10.1007/s00428-023-03549-y. Epub 2023 Apr 29.
2023
AOU San Luigi di Orbassano

Marletta S; Caliò A; Bogina G; Rizzo M; Brunelli M; Pedron S; Marcolini L; Stefanizzi L; Gobbo S; Princiotta A; Porta C; Pecoraro A; Antonelli A; Martignoni G;

First-line avelumab for patients with PD-L1-positive metastatic or locally advanced urothelial cancer who are unfit for cisplatin. in Annals of oncology : official journal of the European Society for Medical Oncology / Ann Oncol. 2022 Nov;33(11):1179-1185. doi: 10.1016/j.annonc.2022.07.011. Epub 2022 Aug 2.
2022
AOU San Luigi di Orbassano

Iacovelli R; Ciccarese C; Brunelli M; Battelli N; Buttigliero C; Caserta C; Buti S; Santini D; Carella C; Galli L; Verri E; Ermacora P; Merler S; Masini C; De Vivo R; Milesi L; Spina F; Rizzo M; Sperduti I; Fornarini G; Tortora G;

De novo metastatic castration sensitive prostate cancer: State of art and future perspectives. in Cancer treatment reviews / Cancer Treat Rev. 2018 Nov;70:67-74. doi: 10.1016/j.ctrv.2018.08.005. Epub 2018 Aug 11.
2018
AOU San Luigi di Orbassano

Mosillo C; Iacovelli R; Ciccarese C; Fantinel E; Bimbatti D; Brunelli M; Bisogno I; Kinspergher S; Buttigliero C; Tucci M; Caffo O; Tortora G;

T1 high-grade bladder carcinoma outcome: the role of p16, topoisomerase-II?, survivin, and E-cadherin. in Human pathology / Hum Pathol. 2016 Nov;57:78-84. doi: 10.1016/j.humpath.2016.06.022. Epub 2016 Jul 26.
2016
AOU San Luigi di Orbassano

Raspollini MR; Luque RJ; Menendez CL; Bollito E; Brunelli M; Martignoni G; Montironi R; Cheng L; Blanca A; Baroni G; Minervini A; Lopez-Beltran A;

Risk Stratification Model for Resected Squamous-Cell Lung Cancer Patients According to Clinical and Pathological Factors. in Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer / J Thorac Oncol. 2015 Sep;10(9):1341-1348. doi: 10.1097/JTO.0000000000000628.
2015
AOU San Luigi di Orbassano

Pilotto S; Sperduti I; Novello S; Peretti U; Milella M; Facciolo F; Vari S; Leuzzi G; Vavalà T; Marchetti A; Mucilli F; Crinò L; Puma F; Kinspergher S; Santo A; Carbognin L; Brunelli M; Chilosi M; Scarpa A; Tortora G; Bria E;

2015
AOU San Luigi di Orbassano

Bria E; Pilotto S; Amato E; Fassan M; Novello S; Peretti U; Vavalà T; Kinspergher S; Righi L; Santo A; Brunelli M; Corbo V; Giglioli E; Sperduti I; Milella M; Chilosi M; Scarpa A; Tortora G;